Gribben J - Search Results

1

Flavopiridol administered as a 24-hour continuous infusion in chronic lymphocytic leukemia lacks clinical activity.

Flinn IW, Byrd JC, Bartlett N, Kipps T, Gribben J, Thomas D, Larson RA, Rai K, Petric R, Ramon-Suerez J, Gabrilove J, Grever MR. Flinn IW, et al. Among authors: gribben j. Leuk Res. 2005 Nov;29(11):1253-7. doi: 10.1016/j.leukres.2005.03.010. Leuk Res. 2005. PMID: 15916806 Clinical Trial.

2

Sustained complete remission of CLL associated with the use of a Chinese herbal extract: case report and mechanistic analysis.

Battle TE, Castro-Malaspina H, Gribben JG, Frank DA. Battle TE, et al. Leuk Res. 2003 Sep;27(9):859-63. doi: 10.1016/s0145-2126(03)00009-2. Leuk Res. 2003. PMID: 12804645

3

Oral fludarabine has significant activity in patients with previously untreated chronic lymphocytic leukemia, and leads to increased STAT1 levels in vivo.

Friedberg JW, Dong DA, Li S, Kim H, Stephans K, Noonan K, Neuberg D, Gribben JG, Fisher DC, Freedman AS, Takvorian T, Jurgens R, Battle TE, Frank DA. Friedberg JW, et al. Leuk Res. 2004 Feb;28(2):139-47. doi: 10.1016/s0145-2126(03)00213-3. Leuk Res. 2004. PMID: 14654078 Clinical Trial.

4

Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins.

Widhopf GF 2nd, Rassenti LZ, Toy TL, Gribben JG, Wierda WG, Kipps TJ. Widhopf GF 2nd, et al. Among authors: gribben jg. Blood. 2004 Oct 15;104(8):2499-504. doi: 10.1182/blood-2004-03-0818. Epub 2004 Jun 24. Blood. 2004. PMID: 15217828 Free article.

5

ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia.

Rassenti LZ, Huynh L, Toy TL, Chen L, Keating MJ, Gribben JG, Neuberg DS, Flinn IW, Rai KR, Byrd JC, Kay NE, Greaves A, Weiss A, Kipps TJ. Rassenti LZ, et al. Among authors: gribben jg. N Engl J Med. 2004 Aug 26;351(9):893-901. doi: 10.1056/NEJMoa040857. N Engl J Med. 2004. PMID: 15329427 Free article.

6

Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia.

Gribben JG, Zahrieh D, Stephans K, Bartlett-Pandite L, Alyea EP, Fisher DC, Freedman AS, Mauch P, Schlossman R, Sequist LV, Soiffer RJ, Marshall B, Neuberg D, Ritz J, Nadler LM. Gribben JG, et al. Blood. 2005 Dec 15;106(13):4389-96. doi: 10.1182/blood-2005-05-1778. Epub 2005 Aug 30. Blood. 2005. PMID: 16131571 Free PMC article. Clinical Trial.

7

The evolving role of alemtuzumab in management of patients with CLL.

Faderl S, Coutré S, Byrd JC, Dearden C, Denes A, Dyer MJ, Gregory SA, Gribben JG, Hillmen P, Keating M, Rosen S, Venugopal P, Rai K. Faderl S, et al. Among authors: gribben jg. Leukemia. 2005 Dec;19(12):2147-52. doi: 10.1038/sj.leu.2403984. Leukemia. 2005. PMID: 16239912

8

Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy.

Byrd JC, Gribben JG, Peterson BL, Grever MR, Lozanski G, Lucas DM, Lampson B, Larson RA, Caligiuri MA, Heerema NA. Byrd JC, et al. J Clin Oncol. 2006 Jan 20;24(3):437-43. doi: 10.1200/JCO.2005.03.1021. Epub 2005 Dec 12. J Clin Oncol. 2006. PMID: 16344317

9

Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemia.

Faderl S, Rai K, Gribben J, Byrd JC, Flinn IW, O'Brien S, Sheng S, Esseltine DL, Keating MJ. Faderl S, et al. Among authors: gribben j. Cancer. 2006 Sep 1;107(5):916-24. doi: 10.1002/cncr.22097. Cancer. 2006. PMID: 16832816 Free article. Clinical Trial.

10

Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997.

Grever MR, Lucas DM, Dewald GW, Neuberg DS, Reed JC, Kitada S, Flinn IW, Tallman MS, Appelbaum FR, Larson RA, Paietta E, Jelinek DF, Gribben JG, Byrd JC. Grever MR, et al. J Clin Oncol. 2007 Mar 1;25(7):799-804. doi: 10.1200/JCO.2006.08.3089. Epub 2007 Feb 5. J Clin Oncol. 2007. PMID: 17283363 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

558 results

Search Page

Filters